Clinical Trial Update: The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating whether [18F] F-FAPI PET-CT changes management in proximal cholangiocarcinoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Snippet

Sponsor: Mara Veenstra, MD | Conditions: Cholangiocarcinoma | Phase 2, Phase 3 | Status: RECRUITING